Emergent Health Corp Stock Performance
| EMGE Stock | USD 0.0009 0.0001 12.50% |
On a scale of 0 to 100, Emergent Health holds a performance score of 4. The firm shows a Beta (market volatility) of -2.3, which means a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Emergent Health are expected to decrease by larger amounts. On the other hand, during market turmoil, Emergent Health is expected to outperform it. Please check Emergent Health's coefficient of variation, maximum drawdown, skewness, as well as the relationship between the total risk alpha and downside variance , to make a quick decision on whether Emergent Health's price patterns will revert.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Emergent Health Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak technical and fundamental indicators, Emergent Health exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Emergent |
Emergent Health Relative Risk vs. Return Landscape
If you would invest 0.09 in Emergent Health Corp on December 17, 2024 and sell it today you would earn a total of 0.00 from holding Emergent Health Corp or generate 0.0% return on investment over 90 days. Emergent Health Corp is currently generating 0.7812% in daily expected returns and assumes 12.7561% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Emergent, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Emergent Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Emergent Health's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Emergent Health Corp, and traders can use it to determine the average amount a Emergent Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0612
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | EMGE | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 12.76 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.78 actual daily | 15 85% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Emergent Health is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Emergent Health by adding it to a well-diversified portfolio.
Emergent Health Fundamentals Growth
Emergent Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Emergent Health, and Emergent Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Emergent Pink Sheet performance.
| Return On Equity | -1.64 | |||
| Return On Asset | -0.36 | |||
| Profit Margin | (2.42) % | |||
| Operating Margin | (1.67) % | |||
| Current Valuation | 1.65 M | |||
| Shares Outstanding | 41.93 M | |||
| Price To Earning | (1.43) X | |||
| Price To Sales | 0.34 X | |||
| Revenue | 989.84 K | |||
| EBITDA | (179.57 K) | |||
| Cash And Equivalents | 496.69 K | |||
| Cash Per Share | 0.01 X | |||
| Debt To Equity | 0.27 % | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | 76.97 K | |||
| Earnings Per Share | (0.01) X | |||
| Total Asset | 1.03 M | |||
| Retained Earnings | 471 K | |||
| Current Asset | 1.03 M | |||
| Current Liabilities | 75 K | |||
About Emergent Health Performance
By analyzing Emergent Health's fundamental ratios, stakeholders can gain valuable insights into Emergent Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Emergent Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Emergent Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Emergent Health Corp. develops and sells regenerative medicine, neutraceuticals, and phytonutritionals. As of August 26, 2014, Emergent Health Corp was taken private. EMERGENT HEALTH operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 6 people.Things to note about Emergent Health Corp performance evaluation
Checking the ongoing alerts about Emergent Health for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Emergent Health Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Emergent Health Corp is way too risky over 90 days horizon | |
| Emergent Health Corp has some characteristics of a very speculative penny stock | |
| Emergent Health Corp appears to be risky and price may revert if volatility continues |
- Analyzing Emergent Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Emergent Health's stock is overvalued or undervalued compared to its peers.
- Examining Emergent Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Emergent Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Emergent Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Emergent Health's pink sheet. These opinions can provide insight into Emergent Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Emergent Pink Sheet analysis
When running Emergent Health's price analysis, check to measure Emergent Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Health is operating at the current time. Most of Emergent Health's value examination focuses on studying past and present price action to predict the probability of Emergent Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emergent Health's price. Additionally, you may evaluate how the addition of Emergent Health to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |